ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
67,193.07
0.38%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. BeiGene Ltd (BGNE)

  7. BeiGene Ltd (BGNE) 뉴스

BGNE

BeiGene (BGNE)

BeiGene Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BGNE
일자시간출처헤드라인심볼기업
2024/05/1607:10Business WireEHA2024: BeiGene präsentiert neues Hämatologie-Portfolio und Pipeline-DatenNASDAQ:BGNEBeiGene Ltd
2024/05/1606:50Business WireBeiGene présente de nouvelles données de portefeuille et de pipeline d'hématologie à l'EHA2024NASDAQ:BGNEBeiGene Ltd
2024/05/1505:01Business WireBeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024NASDAQ:BGNEBeiGene Ltd
2024/05/1004:03Business WireBeiGene meldet Finanzergebnisse für das erste Quartal 2024 und aktuelle GeschäftsentwicklungenNASDAQ:BGNEBeiGene Ltd
2024/05/0922:38Business Wireベイジーン、2024年第1四半期決算および事業に関する最新情報を発表NASDAQ:BGNEBeiGene Ltd
2024/05/0910:02Business WireBeiGene公布2024年第一季財務業績和最新業務情況NASDAQ:BGNEBeiGene Ltd
2024/05/0908:03Business WireBeiGene présente ses résultats financiers du premier trimestre 2024 et ses dernières nouvelles commercialesNASDAQ:BGNEBeiGene Ltd
2024/05/0819:00Business WireBeiGene Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:BGNEBeiGene Ltd
2024/04/2623:34Business WireBeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability ReportNASDAQ:BGNEBeiGene Ltd
2024/04/2520:11Business WireGlobaler Onkologie-Innovator BeiGene präsentiert auf der ASCO-Jahrestagung 2024 neue Daten aus dem gesamten Portfolio für Hämatologie und solide TumoreNASDAQ:BGNEBeiGene Ltd
2024/04/2520:10Business WireBeiGene, innovateur mondial en oncologie, présente de nouvelles données sur l’ensemble de son portefeuille en hématologie et en tumeurs solides lors de la réunion annuelle de l’ASCO 2024NASDAQ:BGNEBeiGene Ltd
2024/04/2505:01Business WireGlobal Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual MeetingNASDAQ:BGNEBeiGene Ltd
2024/04/2408:31Business WireBeiGene reçoit l’approbation de la Commission européenne pour le tislelizumab dans le traitement du cancer du poumon non à petites cellulesNASDAQ:BGNEBeiGene Ltd
2024/04/2408:31Business WireBeiGene erhält von der EU-Kommission die Zulassung für Tislelizumab zur Behandlung von nicht kleinzelligem LungenkrebsNASDAQ:BGNEBeiGene Ltd
2024/04/2319:00Business WireBeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung CancerNASDAQ:BGNEBeiGene Ltd
2024/03/1700:18Business WireBeiGene、化学療法後の進行性または転移性食道扁平上皮癌の治療のためのTEVIMBRA®のFDA承認取得NASDAQ:BGNEBeiGene Ltd
2024/03/1606:13Business Wire百濟神州喜獲FDA批准，TEVIMBRA®將用於晚期或轉移性食管鱗狀細胞癌在化療後的治療NASDAQ:BGNEBeiGene Ltd
2024/03/1605:02Business WireBeiGene reçoit l'approbation de la FDA pour TEVIMBRA® dans le traitement du carcinome épidermoïde de l’œsophage avancé ou métastatique après une chimiothérapieNASDAQ:BGNEBeiGene Ltd
2024/03/1515:06Business WireBeiGene erhält FDA-Zulassung für TEVIMBRA ® zur Behandlung des fortgeschrittenen oder metastasierten Plattenepithelkarzinoms der Speiseröhre nach vorheriger ChemotherapieNASDAQ:BGNEBeiGene Ltd
2024/03/1505:28Business WireBeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior ChemotherapyNASDAQ:BGNEBeiGene Ltd
2024/03/1423:23Business Wireマックス財団、ベイジーン、ベイジーン財団の協力により、低・中所得国の慢性リンパ性白血病患者にBRUKINSA®を初回投与NASDAQ:BGNEBeiGene Ltd
2024/03/1418:31Business WireThe Max Foundation、BeiGene和BeiGene Foundation共同向中低收入國家的慢性淋巴性白血病病患提供首批BRUKINSA®藥物NASDAQ:BGNEBeiGene Ltd
2024/03/1404:01Business WireLes premières doses de BRUKINSA® sont administrées à des patients atteints de leucémie lymphoïde chronique dans des pays à revenus faibles et moyens, grâce à la collaboration de la Max Foundation, de BeiGene et de la BeiGene FoundationNASDAQ:BGNEBeiGene Ltd
2024/03/1404:01Business WireErste Dosen von BRUKINSA ® für Patienten mit chronischer lymphatischer Leukämie in Ländern mit niedrigem und mittlerem Einkommen im Rahmen der Zusammenarbeit von The Max Foundation, BeiGene und der BeiGene FoundationNASDAQ:BGNEBeiGene Ltd
2024/03/1321:00Business WireFirst Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene FoundationNASDAQ:BGNEBeiGene Ltd
2024/03/0807:19Business WireBeiGene Announces FDA Accelerated Approval of BRUKINSA for the Treatment of Relapsed or Refractory Follicular LymphomaNASDAQ:BGNEBeiGene Ltd
2024/03/0620:00Business WireBeiGene to Present Clinical and Preclinical Data from Broad Portfolio and Pipeline at AACR Annual Meeting 2024NASDAQ:BGNEBeiGene Ltd
2024/03/0101:17Business Wireベイジーン、2023年第4・四半期および通期決算と事業に関する最新情報を発表NASDAQ:BGNEBeiGene Ltd
2024/03/0100:00Business WireBeiGene Announces New Efficacy Analysis Comparing BRUKINSA® vs Acalabrutinib in Relapsed or Refractory Chronic Lymphocytic LeukemiaNASDAQ:BGNEBeiGene Ltd
2024/02/2909:56Business WireBeiGene publie ses résultats financiers du quatrième trimestre et de l’exercice 2023 et ses mises à jour commercialesNASDAQ:BGNEBeiGene Ltd
 검색 관련기사 보기:NASDAQ:BGNE

최근 히스토리

UNSW3
ARIA20ETH
ARIANEE
EU
7804T
7804T
BOV
PETRI332
PETRI332 Ex:29,09
BITMOT
908493
Hvl Bz 2 Tv Eur3m+1,1 Ot...
NASDAQ
WLSC
NASDAQ
DVAX
Dynavax Technologies
EU
AFLAX
Agence France Locale AFL...
MRTX
HANDETH
ShowHand
NASDAQ
DTYL
Barclays Bank PLC
BIT
SLVR
WisdomTree Silver
BOV
RAILT185
RAILT185 Ex:18,41
AMEX
AMA.L
BINA
TNTETH
NASDAQ
OLLI
Ollies Bargain Outlet
HUOB
BLZETH
Bluzelle
LSE
0OJ8
Fabryki Sprzetu I Narzed...
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유